# @jennymollen on Instagram

- **Type:** Video
- **Original URL:** https://www.instagram.com/p/DTTCobBjX23
- **Gondola URL:** https://gondola.cc/posts/38631621-jennymollen-instagram
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/postThumbnails/e5a3d7ab06.jpg
- **Posted:** 2026-01-09T17:00:05.000+00:00
- **Account Owner:** Jenny Mollen (@jennymollen) — https://gondola.cc/jennymollen

## Caption

#AD If my frown lines could talk, they’d say “Give us the peptide formulation!”

Meet daxxify — the first and only neurotoxin formulated with a peptide (aka the first big innovation in frown line treatments in 20 years 👏).

✨ Fast results (sometimes as soon as the next day and typically within 2!)

✨ Long-lasting smoothing

✨ That glowy, radiant finish I’m obsessed with

I made the switch — have you? 💜

P.S. There’s $50 rebate when your get DAXXIFY® now! Head to daxxify.com/get50 to learn more.
#DAXXIFY #Neuromodulators #Neurotoxin
For Full Prescribing Information including Boxed Warning and Medication Guide, see daxxifypi.
DAXXIFY® (daxibotulinumtoxinA-lanm) for injection is a prescription medicine for adults to temporarily improve the look of moderate to severe frown lines between the eyebrows. Ask your doctor to tell you about DAXXIFY®. DAXXIFY® may cause serious side effects hours to weeks after injection. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems or muscle weakness can be a sign of a life-threatening condition. The most common side effects are headache, eyelid drooping, and loss of the ability to move some muscles in your face.
Call your doctor for medical advice about side effects. Intended for US audiences.
$50 rebate will be awarded as a prepaid e-gift card. Claims must be received by 4/6/26. See Terms & Conditions for details.
74% achieved a > 2-grade improvement at week 4 per both physician’s and patient’s assessment. In clinical trial diaries, patients reported seeing a measurable improvement within 2 days of treatment. More than 50% had no or minor frown lines until 6 months after treatment per both physician’s and patient’s assessments. In an open-label study (N=27), 89% of patients agreed their skin looked radiant/bright (exploratory endpoint).

## Stats

- **Views:** 7,756
- **Likes:** 408
- **Shares:** 0
- **Comments:** 27

## Tags

neurotoxin, ad, neuromodulators, daxxify

---
Copyright (c) Gondola